PD CEN/TS 16835-2:2015
分子体外诊断检查.静脉全血预审流程的规范.第2部分:脱氧核糖核酸染色体组的分离

Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 2: Isolated genomic DNA


标准号
PD CEN/TS 16835-2:2015
发布
2015年
发布单位
欧洲标准化委员会
当前最新
PD CEN/TS 16835-2:2015
 
 
引用标准
EN ISO 15189:2012 EN ISO 22174:2005 ISO 15190:2003 ISO Guide 30:2015
被代替标准
FprCEN/TS 16835-2-2015
适用范围
This Technical Specification recommends the handling, documentation and processing of venous whole blood specimens intended for genomic DNA analysis during the preanalytical phase before a molecular assay is performed. This Technical Specification covers specimens collected by venous whole blood collection tubes. This Technical Specification is applicable to molecular in vitro diagnostic examinations (e. g. in vitro diagnostic laboratories, laboratory customers, in vitro diagnostics developers and manufacturers, institutions and commercial organizations performing biomedical research, biobanks, and regulatory authorities). Blood genomic DNA can fragment or degrade after blood collection. Therefore, special measures need to be taken to secure good quality blood samples for genomic DNA analysis. This is particularly relevant for analytical test procedures requiring high molecular weight DNA. Different dedicated measures need to be taken for preserving blood circulating cell free DNA, which are not described in this Technical Specification. Circulating cell free DNA in blood is covered in CEN/TS 16835-3, Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma. Different dedicated measures need to be taken for collecting, stabilizing, transporting and storing capillary blood as well as for blood collected and stored by paper based technologies. These are not described in this Technical Specification. DNA from pathogens present in blood is not covered by this Technical Specification.

PD CEN/TS 16835-2:2015相似标准


推荐

被神化无创产前检测

合并恶性肿瘤孕妇:恶性肿瘤细胞染色体和基因多发生变异,可能肿瘤本身即含有T21、T18或T13异常细胞,细胞凋亡后释放异常基因DNA进入母体血浆中,将导致NIPT出现假阳性。不适用人群:1. 染色体异常胎儿分娩史,夫妇一方明确有染色体异常。2. 1年内接受过异体输血、移植手术、细胞治疗或免疫治疗3. 胎儿影像学检查怀疑胎儿有微缺失微重复综合征或其他染色体异常4. ...

被神化产前检测

合并恶性肿瘤孕妇:恶性肿瘤细胞染色体和基因多发生变异,可能肿瘤本身即含有T21、T18或T13异常细胞,细胞凋亡后释放异常基因DNA进入母体血浆中,将导致NIPT出现假阳性。不适用人群:1. 染色体异常胎儿分娩史,夫妇一方明确有染色体异常。2. 1年内接受过异体输血、移植手术、细胞治疗或免疫治疗3. 胎儿影像学检查怀疑胎儿有微缺失微重复综合征或其他染色体异常4. ...

关注蜜糖天使,防控出生缺陷

就目前医学技术水平来说,唐氏儿尚无法治愈,只能在出生前孕检避免或者后天教导减轻唐氏综合征对患儿伤害。传统唐筛 在我国,唐筛是每个孕妇必做一项重要检查。通过抽取孕妇静脉,检测血液中甲胎蛋白A(AFP)、人绒毛膜性腺激素(β-hCG)和游离雌三醇(uE3)等指标,结合超声等检查,评估胎儿患病风险。产前诊断 对于筛查提示高风险或单项指标异常孕妇,建议行产前诊断。...

【国家级文件】:NGS检测试剂生产应获得医疗器械许可证

NGS检测试剂生产企业应获得《医疗器械生产许可证》。研制、生产用各种原料、辅料等应制定其相应质量标准,并应符合有关法规要求。2. 试剂生产企业生产质量管理体系应符合《医疗器械生产质量管理规范》及《医疗器械生产质量管理规范附录体外诊断试剂》要求,并应通过《医疗器械生产质量管理规范体外诊断试剂现场检查指导原则》核查。3....





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号